Skip to main content

Advertisement

Log in

Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Background

Whether type 2 diabetes is cause or consequence, or both, of pancreatic cancer (PaC) remains unresolved. Leveraging repeated measurements of fasting blood glucose (FBG), we examined the temporal relationship between hyperglycemia and PaC incidence.

Methods

We conducted a nested case–control study of 278 cases and 826 matched-controls from the Korean National Health Insurance Service-Health Screening Cohort. Over 11 years before index date (date of PaC diagnosis for cases), all participants had at least one FBG measurement in each of the three time windows: − 11 to − 8, − 7 to − 4, and − 3 to 0 years. Using conditional logistic regression, we estimated odds ratios(ORs) of PaC and 95% confidence intervals (CIs) for hyperglycemia in the overall period and at each interval; for major long-term patterns of FBG across the three intervals (recent-onset, medium-term, and long-standing hyperglycemia).

Results

Higher FBG over the past 11 years was associated with an increased odds of PaC (p trend < .0001), with recent FBG more predictive of PaC than distant FBG. By FBG assessed in the − 3 to 0 interval, OR was 1.97 (95% CI 1.32–2.93) for 110–125 mg/dL and 3.17 (95% CI 2.09–4.80) for ≥ 126 mg/dL. By long-term patterns of FBG, compared to consistent normoglycemia, OR was 2.02 (95% CI 1.24–3.31) for long-standing hyperglycemia and 3.38 (95% CI 1.87–6.13) for recent-onset hyperglycemia. These associations were more pronounced among never-smokers than ever-smokers (p interaction = .06).

Conclusion

Recent-onset hyperglycemia may be an early manifestation of undetected PaC, while long-lasting hyperglycemia may serve as a moderate etiologic factor for PaC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30

    Article  PubMed  Google Scholar 

  2. International Agency for Research on Cancer. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accessed 21 Feb 2017

  3. The US National Cancer Institute. Cancer Stat Facts: Pancreas Cancer. https://seer.cancer.gov/statfacts/html/pancreas.html. Accessed 21 Feb 2017

  4. Yachida S, Iacobuzio-Donahue CA (2013) Evolution and dynamics of pancreatic cancer progression. Oncogene 32:5253–5260

    Article  CAS  PubMed  Google Scholar 

  5. Muniraj T, Chari ST (2012) Diabetes and pancreatic cancer. Minerva gastroenterologica e dietologica 58:331–345

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Pannala R, Basu A, Petersen GM, Chari ST (2009) New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 10:88–95

    Article  PubMed  PubMed Central  Google Scholar 

  7. Han L, Ma Q, Li J et al (2011) High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. PLoS ONE 6:e27074

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sah RP, Nagpal SJS, Mukhopadhyay D, Chari ST. (2013) New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastrol Hepatol 10:423–433

    Article  CAS  Google Scholar 

  10. Pang JX, Hsu JP, Yeo TW, Leo YS, Lye DC (2017) Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: a matched case–control study. Sci Rep 7:39872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Fisher-Hoch SP, Vatcheva KP, Rahbar MH, McCormick JB (2015) Undiagnosed diabetes and pre-diabetes in health disparities. PLoS ONE 10:e0133135

    Article  PubMed  PubMed Central  Google Scholar 

  12. Chari ST, Leibson CL, Rabe KG et al (2008) Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 134:95–101

    Article  CAS  PubMed  Google Scholar 

  13. Quan H, Sundararajan V, Halfon P et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical Care 43:1130–1139

    Article  PubMed  Google Scholar 

  14. American Diabetes Association (2010) Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62–S69

    Article  PubMed Central  Google Scholar 

  15. Ardisson Korat AV, Willett WC, Hu FB (2014) Diet, lifestyle, and genetic risk factors for type 2 diabetes: a review from the Nurses’ Health Study, Nurses’ Health Study 2, and Health Professionals’ follow-up study. Curr Nutr Rep 3:345–354

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kahn SE, Prigeon RL, Schwartz RS et al (2001) Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr 131:354S–360S

    CAS  PubMed  Google Scholar 

  17. Lim U, Ernst T, Buchthal SD et al (2011) Asian women have greater abdominal and visceral adiposity than Caucasian women with similar body mass index. Nutr Diabetes 1:e6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hu FB (2011) Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 34:1249–1257

    Article  PubMed  PubMed Central  Google Scholar 

  19. Liao WC, Tu YK, Wu MS, Lin JT, Wang HP, Chien KL. (2015) Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ-Brit Med J 349:g7371

    Article  Google Scholar 

  20. Ramlo-Halsted BA, Edelman SV (1999) The natural history of type 2 diabetes: implications for clinical practice. Primary Care 26:771–789

    Article  CAS  PubMed  Google Scholar 

  21. Wolpin BM, Bao Y, Qian ZR et al (2013) Hyperglycemia, insulin resistance, impaired pancreatic -cell function, and risk of pancreatic cancer. JNCI-J Natl Cancer Inst 105:1027–1035

    Article  Google Scholar 

  22. Mayers JR, Wu C, Clish CB et al (2014) Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med 20:1193–1198

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Cohen R, Neuzillet C, Tijeras-Raballand A, Faivre S, de Gramont A, Raymond E (2015) Targeting cancer cell metabolism in pancreatic adenocarcinoma. Oncotarget 6:16832–16847

    Article  PubMed  PubMed Central  Google Scholar 

  24. Boroughs LK, DeBerardinis RJ (2015) Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol 17:351–359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Vincent A, Herman J, Schulick R, Hruban RH, Goggins M (2011) Pancreatic cancer. Lancet 378:607–620

    Article  PubMed  PubMed Central  Google Scholar 

  26. Sinacore DR, Gulve EA. (1993) The role of skeletal muscle in glucose transport, glucose homeostasis, and insulin resistance: implications for physical therapy. Phys Ther 73:878–891

    Article  CAS  PubMed  Google Scholar 

  27. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961–969

    Article  CAS  PubMed  Google Scholar 

  28. Hu Y, Bhupathiraju SN, de Koning L, Hu FB (2014) Duration of obesity and overweight and risk of type 2 diabetes among US women. Obesity 22:2267–2273

    Article  PubMed  PubMed Central  Google Scholar 

  29. Hu FB, Leitzmann MF, Stampfer MJ, Colditz GA, Willett WC, Rimm EB (2001) Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 161:1542–1548

    Article  CAS  PubMed  Google Scholar 

  30. Grontved A, Pan A, Mekary RA et al (2014) Muscle-strengthening and conditioning activities and risk of type 2 diabetes: a prospective study in two cohorts of US women. PLoS Med 11:e1001587

    Article  PubMed  PubMed Central  Google Scholar 

  31. Munigala S, Singh A, Gelrud A, Agarwal B (2015) Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus. Clin Transl Gastroenterol 6:e118

    Article  PubMed  PubMed Central  Google Scholar 

  32. Davidson MB, Schriger DL, Peters AL, Lorber B (1999) Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281:1203–1210

    Article  CAS  PubMed  Google Scholar 

  33. Pang Y, Kartsonaki C, Guo Y et al. (2017) Diabetes, plasma glucose and incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies. Int J Cancer 140:1781

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study used NHIS-HealS data (NHIS-2017-2-304) made by National Health Insurance Service (NHIS).

Funding

This work was supported by a Grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI13C0715). Dr. Bao was supported by NIH Grants KL2 TR001100, U54CA155626 and P30 DK046200, and by Department of Defense Grant CA150357.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyeon Chang Kim.

Ethics declarations

Conflict of interest

The author(s) declare no conflict of interest with NHIS.

Electronic supplementary material

Below is the link to the electronic supplementary material.

10552_2017_988_MOESM1_ESM.jpg

Supplementary Fig. 1 Median Fasting Blood Glucose of Case and Control Groups across Time Windows before Index Date (JPG 31 KB)

Supplementary material 2 (DOC 33 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Keum, N., Ha, K.H., Bao, Y. et al. Long-term patterns of fasting blood glucose levels and pancreatic cancer incidence. Cancer Causes Control 29, 135–142 (2018). https://doi.org/10.1007/s10552-017-0988-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-017-0988-6

Keywords

Navigation